Historical Stock Price
ETFs Holding RPRX »    Stock Splits Calendar »



Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
07/08/2024 $25.76 $25.77 $25.43 $25.71 2.24M
07/09/2024 $25.62 $25.68 $25.20 $25.63 1.85M
07/10/2024 $25.62 $25.75 $25.46 $25.73 2.25M
07/11/2024 $25.96 $26.84 $25.94 $26.73 2.91M
07/12/2024 $27.00 $27.04 $26.70 $26.77 1.96M
Royalty Pharma is a buyer of biopharmaceutical royalties. The royalties in Co.'s marketed portfolio related to approved products include: cystic fibrosis franchise, which consists of Co.'s right to receive royalty payments on the sale of various products for use in the treatment of cystic fibrosis, including Kalydeco (ivacaftor), Orkambi (lumacaftor and ivacaftor), Symdeko/Symkevi (tezacaftor and ivacaftor) and Trikafta/Kaftrio (elexacaftor, tezacaftor and ivacaftor); and Tysabri, which is a monoclonal antibody for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.
RPRX historical stock prices picture
Royalty Pharma (RPRX) has the following price history information. Looking back at RPRX historical stock prices for the last five trading days, on July 08, 2024, RPRX opened at $25.76, traded as high as $25.77 and as low as $25.43, and closed at $25.71. Trading volume was a total of 2.24M shares. On July 09, 2024, RPRX opened at $25.62, traded as high as $25.68 and as low as $25.20, and closed at $25.63. Trading volume was a total of 1.85M shares. On July 10, 2024, RPRX opened at $25.62, traded as high as $25.75 and as low as $25.46, and closed at $25.73. Trading volume was a total of 2.25M shares. On July 11, 2024, RPRX opened at $25.96, traded as high as $26.84 and as low as $25.94, and closed at $26.73. Trading volume was a total of 2.91M shares. On July 12, 2024, RPRX opened at $27.00, traded as high as $27.04 and as low as $26.70, and closed at $26.77. Trading volume was a total of 1.96M shares.

RPRX Historical Stock Prices By Date:

RPRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Royalty Pharma shares, starting with a $10,000 purchase of RPRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 06/16/2020
End date: 07/12/2024
Start price/share: $44.50
End price/share: $26.77
Starting shares: 224.72
Ending shares: 243.92
Dividends reinvested/share: $2.96
Total return: -34.70%
Average Annual Total Return: -9.93%
Starting investment: $10,000.00
Ending investment: $6,530.72
Years: 4.07
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/16/2020
End date: 07/12/2024
Start price/share: $44.50
End price/share: $26.77
Dividends collected/share: $2.96
Total return: -33.19%
Average Annual Total Return: -9.43%
Starting investment: $10,000.00
Ending investment: $6,679.68
Years: 4.07
Date Close
07/08/2024$25.71
07/09/2024$25.63
07/10/2024$25.73
07/11/2024$26.73
07/12/2024$26.77
RPRX is categorized under the Healthcare sector; below are some other companies in the same sector:

RPTP Historical Stock Prices
RSLS Historical Stock Prices
RTGN Historical Stock Prices
RTIX Historical Stock Prices
RTRX Historical Stock Prices
RTTR Historical Stock Prices
RUBY Historical Stock Prices
RVMD Historical Stock Prices
RVNC Historical Stock Prices
RVP Historical Stock Prices

Also explore: RPRX shares outstanding history

Email EnvelopeFree RPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

RPRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.